טוען...
Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer
BACKGROUND: Prostate cancer is one of the most prevalent cancers in males in the United States and amongst the leading causes of cancer related deaths. A particularly virulent form of this disease is castration-resistant prostate cancer (CRPC), where patients no longer respond to medical or surgical...
שמור ב:
| הוצא לאור ב: | BMC Bioinformatics |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5374594/ https://ncbi.nlm.nih.gov/pubmed/28361666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12859-017-1522-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|